Press Releases
SunCar Technology Group Announces Share Repurchase Program
NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- SunCar Technology Group Inc. (“SunCar” or the “Company”) (NASDAQ: SDA), a Cayman Islands exempted company, today announced that its board of directors has authorized a share repurchase program to buy back up to $10 million of its outstanding Class A ordinary shares, par value $0.0001 per share (the “Class A Ordinary Shares”). This program reflects the Company's confidence in its long-term growth prospects...
SuperCom to Report Third Quarter 2026 Financial Results on November 12th, 2026
TEL AVIV, Israel, Nov. 6, 2026 /PRNewswire/ -- SuperCom (NASDAQ: SPCB), a global provider of secure solutions for the IoT, cybersecurity, and digital identity sectors, will hold a conference call on Thursday, November 12, 2026, at 10 a.m. Eastern time (7 a.m.
HCW Biologics Presents Newly Identified Distinctive Features of Its Lead T Cell Engager Candidate Built with Company's Proprietary T-Cell Engager Platform, Further Supporting Its Use in Treating Solid Tumors at the Society for Immunotherapy of Cancer's 41st Annual Meeting
HCW11-018b induces/promotes tertiary lymphoid structure formation inside tumors HCW11-018b converts immunological “cold” tumors into “hot” tumors HCW11-018b was generated using the Company's non-Fc TRBC platform, combining elements that enhance T-cell activation and tumor infiltration while mitigating immunosuppression MIRAMAR, Fla., Nov. 06, 2026 (GLOBE NEWSWIRE) -- -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company and leading developer in novel multi-functional fusion immunotherapeutics, for the treatment of autoimmune diseases, cancer, and senescence-associated dysplasia, announced a major update for its multivalent, second-generation T-Cell Engager (“TCE”) Program, presented at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (“SITC”), taking place from November 4 – 8, 2026, in Phoenix, Arizona...
Cyabra Secures Six-Figure Agreement with Major Media Company to Detect Coordinated Online Manipulation
AI-Powered Narrative Intelligence Will Help Distinguish Authentic Audience Reaction from Coordinated Amplification and Identify Impersonation Threats
iRhythm Holdings to Participate in Upcoming Investor Conferences
SAN FRANCISCO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today announced that it will participate in the following investor conferences.
Caterpillar Group President of Construction Industries Rod Shurman to Participate in Fireside Chat Hosted by Chad Dillard of Bernstein
IRVING, Texas, Nov. 6, 2026 /PRNewswire/ -- Caterpillar Inc. (NYSE: CAT) Group President of Construction Industries Rod Shurman is expected to participate in a fireside chat hosted by Chad Dillard of Bernstein in North Carolina on Tuesday, Nov. 17, from 11:15 a.m. to noon ET.
XTEND AI Robotics, Inc. Receives $8.3 Million Defense Order for Systems in Asia-Pacific
TAMPA, Fla.--(BUSINESS WIRE)--XTEND AI Robotics, Inc. (NYSE: XTND) (“XTEND” or the “Company”), a leader in software systems and Physical AI, today announced that its Asia-Pacific subsidiary, Performance Rotors Pte Ltd, has received a purchase order valued at approximately $8.3 million from a defense customer in the region. The order covers multiple unmanned aerial systems, with associated ground control stations and accessories, and includes a first-year software update package for every system...
FOX CORPORATION COMPLETES ACQUISITION OF ROKU
FOX Is Now One of the Leading Streaming Businesses in the U.S., Inclusive of Roku, Tubi and FOX One Roku's Open Distribution Platform to Continue Serving More Than 100 Million Households Worldwide, with Access to Thousands of Apps and Channels Across the Streaming TV Ecosystem NEW YORK, Nov. 6, 2026 /PRNewswire/ -- Fox Corporation (Nasdaq: FOXA, FOX) ("FOX" or the "Company") today announced the successful completion of its acquisition of Roku, Inc. (Nasdaq: ROKU) ("Roku"). With this acquisition FOX has entered a new transformational era – creating an innovative scaled media and technology company with superior reach, engagement and monetization capabilities...
Align Technology Announces $270 Million Accelerated Stock Repurchase Agreement
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement (“ASR”) with Goldman Sachs & Co. LLC (“Goldman Sachs”), to repurchase $270 million of Align's common s...
Phio Pharmaceuticals Announces Invitation for Oral Presentation at 41st Annual SITC Meeting (Society for Immunotherapy of Cancer)
INTASYL siRNA - Redefining the Treatment Paradigm for Cutaneous Squamous Cell Carcinoma King of Prussia, Pennsylvania--(Newsfile Corp. - November 6, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL gene silencing technology to eliminate cancer. Phio announced today that it will present clinical data from its Phase 1b clinical trial at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC), which will be held in Phoenix, Arizona from November 6-8, 2026...
Marvell Technology, Inc. Announces Conference Call to Review Third Quarter of Fiscal Year 2027 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today announced it will conduct a conference call following the release of its third quarter of fiscal year 2027 financial results on Tuesday, December 1, 2026, at 1:30 p.m. Pacific Time. Conference Call Interested parties may join the live conference call without operator assistance at Call me™ (link will be active approximately 30 minutes before the call) to...
Obsidian Therapeutics to Present Updated Amsoki-cel Efficacy and Pooled Safety Data in Advanced Melanoma at SITC 2026 Annual Meeting
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Obsidian Therapeutics, Inc. (Nasdaq: OBX), a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies, today announced positive updated results in patients with immune-checkpoint inhibitor (ICI)-resistant advanced melanoma from the Phase 1 single-center first-in-human (FIH) study and the Phase 1/2 Agni-01 multicenter study of amsokigene autoleucel (amsoki-ce...
Aulos Bioscience's Imneskibart Demonstrates Outstanding Phase 2 Activity in Checkpoint Inhibitor-Refractory Melanoma and Lung Cancer, Comparing Favorably With Historical Treatment Benchmarks
LARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic, imneskibart (AU-007), today announced positive Phase 2 data demonstrating clinical activity with imneskibart-based regimens in heavily pretreated patients with doublet checkpoint inhibitor (CPI)-refractory melanoma and CPI-refractory adenocarcinoma non-small cell lung cancer (NSCLC). The findings, presented i...
Insperity to Participate in the J.P. Morgan 2026 Ultimate Services Investor Conference
HOUSTON--(BUSINESS WIRE)--Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America's best businesses, announced today that Paul Sarvadi, Chairman and Chief Executive Officer, and Jim Allison, Chief Financial Officer, will speak at the J.P. Morgan Ultimate Services Investor Conference on November 17, 2026. The fireside chat presentation is scheduled for 3:20 p.m. Eastern Time. A live audio webcast of the fireside chat presentation will be...
Agenus Reports More Than Half of Patients with Refractory MSS Metastatic Colorectal Cancer Achieved Long-Term Survival Following BOT+BAL Treatment at SITC 2026
LEXINGTON, Mass.--(BUSINESS WIRE)---- $AGEN #Botensilimab--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced new findings from a long-term survivor analysis of its Phase 1b C-800-01 trial evaluating botensilimab (BOT), a multifunctional, Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), an anti-PD-1 antibody, in heavily pretreated patients with microsatellite-stable (MSS) metastatic colorectal cancer (mCRC) without active liver metastases. The results were prese...
The Estée Lauder Companies Unveils Mastering Skin Longevity, a Breakthrough Scientific Innovation Platform Advancing the Next Era of Skin Science
SHANGHAI--(BUSINESS WIRE)--At the China International Import Expo (CIIE), The Estée Lauder Companies Inc. (NYSE: EL) today unveiled Mastering Skin Longevity, a breakthrough scientific innovation platform designed to advance the next era of skin science and transformative product innovation. Moving beyond the study of individual Hallmarks of Aging, the platform focuses further upstream on the Master Regulators of Skin Longevity. These interconnected biological pathways and proteins influence mul...
lululemon Introduces the Ventscape™ Run Vest – A Product Innovation that Simplifies Cold-Weather Running
VANCOUVER, British Columbia--(BUSINESS WIRE)--lululemon (NASDAQ: LULU) today unveiled the Ventscape™ PrimaLoft ThermoPlume+ Run Vest, a new product innovation for cold-weather running, during the 2026 China International Import Expo. Runners in cold environments often experience distractions that can pull their focus, such as changing thermal needs, sweat, and the need to adjust layers. Ventscape addresses these issues by offering a more comfortable and consistent thermal experience from the...
Donaldson Company to Present at the Baird 2026 Global Industrial Conference
MINNEAPOLIS--(BUSINESS WIRE)--Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, today announced Rich Lewis, president and chief executive officer, will present at the Baird 2026 Global Industrial Conference in Chicago, Illinois on Wednesday, November 11, beginning at 2:20 p.m. CT. About Donaldson Company Founded in 1915, Donaldson (NYSE: DCI) is a global leader in technology-led filtration products and solutions, serving a broad r...
Purple Celebrates "Grid Day" with the Grid It Forward Campaign, Gifting Hundreds of Mattresses to Customers and Their Loved Ones
The inventor of the GelFlex Grid celebrates its loyal community with mattress giveaways, exclusive showroom offers and holiday savings SALT LAKE CITY, Nov. 6, 2026 /PRNewswire/ -- Purple Innovation, Inc ("Purple"), (NASDAQ: PRPL) the world leader in sleep technology and inventor of GelFlex Grid, today announced November 7th as "Grid Day," marking the launch of its annual campaign, Grid It Forward. Grid Day was born from Purple's "original gridders" (OG's) and most loyal fans...
IMUNON Presents New Translational Data at SITC 2026 Demonstrating How IMNN-001 Activates and Sustains Anti-Tumor T-Cell Immunity in Advanced Ovarian Cancer
Analysis of paired patient biopsies from the randomized Phase 2 OVATION 2 study shows IMNN-001 increased CD8+/Treg, CD8+/CD4+ and CD8+/IDO+ ratios in both tumor and stroma
The Palm Tree Club & Hotel Miami is Turning into Hote.l.f
Palm Tree Crew and e.l.f. Brands bring beauty, music and culture together for a multi-day Art Basel Miami takeover MIAMI, Nov. 6, 2026 /PRNewswire/ -- This Art Basel Miami, the Palm Tree Club & Hotel is getting a glow-up.
Eguana Announces Completion of Second and Final Tranche and Closing of Previously Announced Convertible Debenture Financing
Calgary, Alberta--(Newsfile Corp. - November 6, 2026) - Eguana Technologies Inc. (TSXV: EGT) ("Eguana" or the "Company") announces that it has completed the second tranche of its previously announced convertible debenture financing (the "Financing"), consisting of the issuance of 35 subordinated secured convertible debentures (the "Debentures") for gross proceeds of C$35,000. Together with the first tranche of 465 Debentures for gross proceeds of C$465,000 completed on October 21, 2026, the Company has issued an aggregate of 500 Debentures for aggregate gross proceeds of C$500,000, and the Financing is now closed...
Cineverse to Report Second Quarter Fiscal 2027 Financial Results on Friday, November 13, 2026
LOS ANGELES, Nov. 6, 2026 /PRNewswire/ -- Cineverse Corp. (Nasdaq: CNVS), an entertainment technology company and studio, announced today that it will release its financial results for the second quarter fiscal year 2027 ending September 30, 2026, before the market opens on Friday, November 13, 2026. Cineverse will host a conference call discussing these results at 8:30 a.m...
Atebimetinib Combinations with Anti-PD1 Cured 50% of Mice in a RAS-Mutant Colorectal Cancer Model and Nearly Doubled Survival in a RAS-Mutant Lung Cancer Model; New Data Presented at SITC 2026
- Durable complete regressions observed in 50% of mice in a RAS-mutant colorectal cancer model treated with Atebimetinib plus anti-PD-1, with no regrowth even after dosing stopped - - Median survival extended by 1.8-fold with atebimetinib plus anti-PD-1 and chemotherapy versus anti-PD-1 plus chemotherapy alone in a RAS-mutant lung cancer model - - Pulsatile MEK inhibition reversed MAPK-driven immune suppression by lowering suppressive myeloid cells and regulatory T-cells, and expanding NK cells, while avoiding T-cell signaling attenuation associated with continuous MAPK inhibition - - Phase 2 clinical trial of atebimetinib in combination with anti-PD-1 and platinum-doublet chemotherapy in first-line RAS-mutant NSCLC is expected to dose the first patient by year-end - NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced compelling preclinical data demonstrating that atebimetinib, the Company's novel Deep Cyclic Inhibitor of MEK, enhanced the activity of PD-1 checkpoint blockade in RAS-mutant colorectal and lung cancer models, including a 50% durable complete regression rate in a colorectal model and a 1.8-fold median survival improvement with a triple combination in a lung model. The data are being presented at the Society for Immunotherapy of Cancer (SITC) 41st Annual Meeting, taking place November 4-8, 2026, in Phoenix, Arizona...
Remitly Announces Upcoming Webinar and Investor Conference Participation
SEATTLE, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of financial services that transcend borders, today announced that its management team will present at the following investor conferences: Post-Earnings Virtual Webinar with Keybanc Date: Monday, November 9, 2026 Time: 11 a.m. Eastern Time / 8 a.m...
Volaris Reports October 2026 Traffic Results: International Represents 50% of Total Capacity for the Month
MEXICO CITY, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central and South America, reports its October 2026 preliminary traffic results...
Experian Named a Leader in 2026 IDC MarketScape for Worldwide Decision Intelligence Platforms
COSTA MESA, Calif.--(BUSINESS WIRE)--Experian today announced it has been named a Leader in the IDC MarketScape: Worldwide Decision Intelligence Platforms 2026 Vendor Assessment (Doc #US54118426, September 2026), which evaluates providers helping organizations design, engineer and orchestrate increasingly complex decisions. “As organizations embed AI into more consequential decisions, the combination of trusted data, advanced analytics and strong governance becomes increasingly important,” said...
Starfighters Space Reschedules Investor Update to Nov. 20
KENNEDY SPACE CENTER, Fla.--(BUSINESS WIRE)--Starfighters Space, Inc. ("Starfighters" or the "Company") (NYSE American: FJET), the space company operating the world's only commercial fleet of flight-ready Mach 2+ supersonic aircraft, must reschedule a live briefing by CEO Tim Franta from Nov. 6 to Nov. 20. A newly announced visit by senior government officials to the Company's hangar at Kennedy Space Center on Nov. 6 will require Mr. Franta's presence during the hours previously planned for the...
Candel Therapeutics Presents SITC 2026 Data Highlighting Systemic Immune Activation and Survival Outcomes Across Clinical-Stage Portfolio
Three posters, including a late-breaking presentation, provide new clinical and biomarker data for aglatimagene besadenovec (aglatimagene) in localized prostate cancer and non-small cell lung cancer (NSCLC), and for linoserpaturev in recurrent glioblastoma PrTK05 data show systemic cytotoxic T-cell activation following intraprostatic administration of aglatimagene in intermediate-risk localized prostate cancer, together with data consistent with transient biodistribution and shedding, supporting the planned BLA submission In progressive non-squamous NSCLC, longitudinal immune changes in blood and tumor tissue and specific multi-omic features were associated with survival beyond 24 months, supporting the biological rationale for the ongoing phase 3 AURORA trial Linoserpaturev data in recurrent glioblastoma showed durable survival in a subset of patients following treatment, alongside persistent tumor T-cell infiltration and exploratory immune changes that may inform strategies to further enhance and sustain antitumor activity NEEDHAM, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced clinical and biomarker data from three poster presentations at the Society for Immunotherapy of Cancer's (SITC) 41st Annual Meeting, taking place November 4—8, 2026, in Phoenix, Arizona...
Seanergy Maritime Announces the Date for the Third Quarter and Nine Months Ended September 30, 2026, Financial Results, Conference Call, and Webcast
Earnings Release: Thursday, November 12, 2026, Before Market Open in New York Conference Call and Webcast: Thursday, November 12, 2026, at 10:00 a.m. Eastern Time
Compass Therapeutics Presents Novel Mechanism of Action Data for CTX-10726 (PD-1 x VEGF-A Bispecific Antibody) at the SITC 2026 Annual Meeting
CTX-10726, a PD-1 x VEGF-A bispecific antibody discovered and engineered at Compass, exhibits a unique mechanism of action that has not been previously reported in this class of drugs, characterized by VEGF-A-dependent cleavage of PD-1 receptors from T cells resulting in conversion of PD-1 positive T cells into PD-1 negative T cells. PD-1 receptor cleavage by CTX-10726 was only observed in the presence of VEGF-A, suggesting targeted activity in the tumor microenvironment...
Minerva Neurosciences Provides Third Quarter 2026 Financial Results and Business Updates
Confirmatory Phase 3 trial of roluperidone (MIN-101C19) ongoing with topline efficacy data expected 2H 2027
United Maritime Announces the Date for the Third Quarter and Nine Months Ended September 30, 2026, Financial Results
Earnings Release: Thursday, November 12, 2026, Before Market Open in New York Earnings Release: Thursday, November 12, 2026, Before Market Open in New York
Immunocore reports third quarter financial results and provides a business update
KIMMTRAK (tebentafusp-tebn) net revenues of $102.2 million in Q3 2026 and net revenues of $324.8 million for the first nine months of 2026, representing 10% year-over-year growth year to date
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
PHILADELPHIA and VANCOUVER, British Columbia, Nov. 06, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, and its majority-owned subsidiary, BriaPro Therapeutics Corp. (“BriaPro”), today announced preclinical findings from four posters at the Society for Immunotherapy of Cancer (SITC) 41th Anniversary Annual Meeting, taking place November 4-8, 2026, in Phoenix, AZ...
Getty Images Confirms Release of Third Quarter 2026 Financial Results on November 16
NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. (“Getty Images”) (OTC Pink: GETYQ), the preeminent source of authentic visual content and coverage, confirmed that it will release third quarter 2026 financial results after market close on Monday, November 16, 2026, as scheduled. It will not hold a conference call and webcast in light of the Company's Chapter 11 restructuring process...
Owlet to Report Third Quarter 2026 Financial Results on November 13, 2026
LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT) plans to announce third quarter 2026 financial results before the market opens on Friday, November 13, 2026. Owlet's President, Chief Executive Officer, and Co-Founder, Kurt Workman, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 8:30 a.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-461-5787 (domestic) or 585-542...
Dual-Channel Isolated Gate Drivers from Diodes Incorporated Enable Flexible, Reliable Half-Bridge and Independent Gate-Drive Topologies for Switching Applications
PLANO, Texas--(BUSINESS WIRE)--Diodes Incorporated (Diodes) (Nasdaq: DIOD) today announces the release of the API21550/API21552 series within its RobustISO™ family of isolation products. These dual-channel isolated gate drivers are designed for system engineers who require robust, high-voltage isolation and reliable signal transmission for power-switch driving. Applications include motor drives, solar inverters, battery management systems (BMS), servers, IT and industrial infrastructures, and h...
Did You Lose Money on MNTN, Inc. Stock? The Law Offices of Howard G.
BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on MNTN, Inc. ("MNTN" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conducting a securities fraud investigation on behalf of MNTN, Inc. (NYSE: MNTN) investors into whether the Company may have violated the federal securities laws. The investigation comes after a November 4, 2026 disclosure concerning MNTN, Inc. Investors with losses on MNTN, Inc. securiti...
Hawkeye Digital Partners With Securitize to Tokenize Its Shares
MIAMI BEACH, Fla.--(BUSINESS WIRE)--Hawkeye Digital, Inc. (OTC: HWKE) (“Hawkeye” or the “Company”), a publicly traded private equity incubator and merchant banking platform, today announced a partnership with Securitize Corp. (NYSE: SECZ) to tokenize the Company's common stock on Ethereum. The partnership will provide eligible shareholders a new way to own Hawkeye: real shares, held in digital form, on modern infrastructure. Unlike synthetic tokens or wrapped products, the tokenized shares will...
Did You Lose Money on Madrigal Pharmaceuticals, Inc. Stock? The Law Offices of Howard G.
BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conducting a securities fraud investigation on behalf of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) investors into whether the Company may have violated the federal securities laws. The investigation comes after a November 3, 2026 disclosure concerning Madrigal P...
Did You Lose Money on Dave, Inc. Stock? The Law Offices of Howard G.
BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on Dave, Inc. ("Dave" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conducting a securities fraud investigation on behalf of Dave, Inc. (NASDAQ: DAVE) investors into whether the Company may have violated the federal securities laws. The investigation comes after a November 4, 2026 disclosure concerning Dave, Inc. Investors with losses on Dave, Inc. securi...
Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Nov. 6, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor.
Mundoro Announces Strategic Investment by Centerra Gold
Vancouver, British Columbia--(Newsfile Corp. - November 6, 2026) - Mundoro Capital Inc. (TSXV: MUN) (OTCQB: MUNMF) (www.mundoro.com) ("Mundoro" or the "Company") is pleased to announce that it has entered into a subscription agreement (the "Subscription Agreement") and an investor rights agreement (the "IRA", and together with the Subscription Agreement, the "Strategic Investment Agreements") dated November 5, 2026 with Centerra Gold Inc. (TSX: CG) (NYSE: CGAU) ("Centerra"), under which Centerra (or an affiliate of Centerra) will make an equity investment in Mundoro by way of a private placement (the "Private Placement"). On closing, Centerra, directly or indirectly, will hold 9.9% of Mundoro's issued and outstanding common shares...
Mundoro Reports 2026 Timok Exploration Results; BHP Continues Trstenik and South Timok Options; Mundoro Regains 100% of Central Timok and Borsko Properties with Five Drill-Ready Porphyry Targets
Vancouver, British Columbia--(Newsfile Corp. - November 6, 2026) - Mundoro Capital Inc. (TSXV: MUN) (OTCQB: MUNMF) (www.mundoro.com) ("Mundoro" or the "Company") is pleased to report the exploration results and technical advances achieved during the first nine months of 2026 across its licenses in the Timok Magmatic Complex ("Timok"), Serbia, and to provide an update on its option agreements with BHP. 2026 BHP Funded Exploration Program Highlights Drilling across four targets...
Green Rain Energy Holdings Advances Renewable Energy Development Opportunities in Agriculture, Targeting Crop Protection, Battery Storage and Reduced Operating Costs
BEVERLY HILLS, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Green Rain Energy Holdings, Inc. (OTCID: GREH), through its Green Rain Development initiative, is advancing its exploration of renewable energy and sustainable infrastructure opportunities designed to address growing challenges facing the agricultural industry...
Orbit International's Power Group Reports Bookings of Approximately $1,700,000 for the Month of October
OPG Bookings Exceed $1,000,000 for Fourth Straight Month VPX Power Supply Year-to-Date Bookings Exceed $5,000,000 HAUPPAUGE, N.Y., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Orbit International Corp. (OTCID Basic Market:ORBT), an electronics manufacturer and software solution provider, today announced that its Orbit Power Group (“OPG”) recorded bookings for the month of October 2026 of approximately $1,700,000...
Algoma Central Corporation Announces Closing of Over-Allotment Option of Additional Debentures
ST. CATHARINES, Ontario--(BUSINESS WIRE)--Algoma Central Corporation (“Algoma”) (TSX:ALC) is pleased to announce that, in connection with its previously announced offering (the “Public Offering”) of $70,000,000 aggregate principal amount of 6.20% convertible unsecured subordinated debentures (the “Debentures”), Algoma has issued an additional $10,500,000 aggregate principal amount of Debentures pursuant to the full exercise of the over-allotment option (the “Over-Allotment Option”) granted to t...
Bernhard Capital Partners and Bowman Consulting Group Announce Completion of Approximately $1 Billion Acquisition
BATON ROUGE, La. and RESTON, Va.
Lotus Tech to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference November 12th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Vontier Declares Regular Dividend
RALEIGH, N.C.--(BUSINESS WIRE)--Vontier Declares Regular Dividend.
Dana Announces Launch of Tender Offers for Any and All of its Outstanding 4.250% Senior Notes due 2030 and 4.500% Senior Notes due 2032
MAUMEE, Ohio, Nov. 6, 2026 /PRNewswire/ -- Dana Incorporated (NYSE: DAN) ("Dana" or the "Company") announced today the commencement of tender offers to purchase for cash any and all of the senior notes issued by the Company listed in the table below (collectively, the "Notes"). The tender offers (each, an "Offer" and, together, the "Offers") are being made pursuant to the Offer to Purchase, dated November 6, 2026 (the "Offer to Purchase")...
QuinStreet to Participate at BMO Financials Conference
FOSTER CITY, Calif.--(BUSINESS WIRE)--QuinStreet, Inc. (Nasdaq: QNST), a leader in performance marketplaces and technologies for the financial services and home services industries, today announced that management will participate at the BMO Financials Conference on November 9 in Boca Raton, FL. The Company looks forward to discussing the details of its performance momentum, market opportunity, and business model with investors. About QuinStreet QuinStreet, Inc. (Nasdaq: QNST) is a leader in pe...
Blackwells Capital Sends Letter to the Board of Trustees of Service Properties Trust
Blackwells demands SVC's Board run a transparent, competitive sale process after rejecting TKO's $2.0B hotel offer, and repeal bylaws that strip owner righ
Draganfly to Host Third Quarter 2026 Shareholder Update Call
Saskatoon, SK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading developer of drone solutions and systems, today announced that it will host a shareholder update and earnings call on November 10, 2026, at 5:30 p.m. EST...
ICU Medical to Present at the 2026 Jefferies Global Healthcare Conference in London
SAN CLEMENTE, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 2026 Jefferies Global Healthcare Conference being held in London, November 15-18, 2026...
CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026
PARSIPPANY, N.J., Nov. 06, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the third quarter ended September 30, 2026, before the market opens on Thursday, November 12, 2026, and will host a corporate update conference call at 8:30 a.m. Eastern Standard Time...
Bath & Body Works Declares Cash Dividend
COLUMBUS, Ohio, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) announced today the declaration of its regular quarterly dividend of $0.20 per share payable on December 4, 2026, to shareholders of record at the close of business on November 20, 2026.
Gogo Announces Third Quarter Results
Gogo Completes Amendment and Extension of its ~$600 Million Original Term Loan B Facility FCC Renews Gogo's Exclusive, Nationwide Air-to-Ground Spectrum Licenses through 2036 Record Galileo Shipments of 172 and 297 Units Online Total Revenue of $213.2 Million, Net loss of $3.2 Million, Adjusted EBITDA1 of $41.0 Million Quarterly Net Cash Provided by Operating Activities of $26.3 Million Reiterates 2026 Financial Guidance BROOMFIELD, Colo., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Gogo Inc. (NASDAQ: GOGO) (“Gogo” or the “Company”), a leading global provider of broadband connectivity services for the business and military/government aviation markets, today announced its financial results for the quarter ended September 30, 2026...
SEALSQ and TechAgency Partner to Guide Organizations Through the Post-Quantum Transition
Geneva, Switzerland , Nov. 06, 2026 (GLOBE NEWSWIRE) -- Joint offering, steered by the SEALSQ Quantum Center of Excellence in Geneva, takes organizations from initial assessment to the execution of their quantum-safe migration
OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook
MINNEAPOLIS, Nov. 06, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced preliminary revenue results for the third quarter ended September 30, 2026, and provides revenue guidance for the fourth quarter of 2026. The Company expects to report revenue of approximately $1 million for the quarter ended September 30, 2026, representing a 242% increase from the prior quarter ended June 30, 2026, and a 465% increase from the prior-year quarter ended September 30, 2025...
Franklin Templeton, Inc. Announces Preliminary Fourth Quarter and Fiscal Year Results
SAN MATEO, Calif.--(BUSINESS WIRE)--Franklin Templeton, Inc. (the “Company”) [NYSE: BEN] today announced preliminary net income1 of $380.1 million or $0.72 per diluted share for the quarter ended September 30, 2026, as compared to net income of $171.5 million or $0.31 per diluted share for the previous quarter, and $117.6 million or $0.21 per diluted share for the quarter ended September 30, 2025. Preliminary net income1 for the fiscal year ended September 30, 2026 was $1,075.3 million or $1.97...
FCC Renews Gogo's Air-to-Ground Spectrum Licenses Through 2036
BROOMFIELD, Colo., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Gogo Inc. (NASDAQ: GOGO) (“Gogo” or the “Company”), a leading global provider of broadband connectivity services for the business and military/government aviation markets, today announced that the Federal Communications Commission (“FCC”) has renewed the Company's Commercial Aviation Air-Ground Radiotelephone licenses for an additional 10-year term, extending Gogo's authorization to operate its exclusive nationwide air-to-ground (“ATG”) spectrum through October 31, 2036...
PNC Bank Expands Branch Buildout to More Than 370, Will Build 60 Branches Per Year
Expansion in South Carolina and Georgia Adds Eight Markets, Bringing Total Buildout Markets to 28 PITTSBURGH, Nov. 6, 2026 /PRNewswire/ -- PNC Bank today announced it will broaden its branch expansion to more than 370 total new locations by 2031, including more than 70 branches already opened since announcing its original expansion strategy. The additional branches will strengthen PNC's presence across the Southeast, adding more than 50 new locations in South Carolina and Georgia, underscoring the company's commitment to two of the nation's fastest-growing states...
Callaway Golf Announces U.S. Investment to Lead a New Era of Golf Club Performance
New Texas 3D printing facility will expand Callaway's advanced manufacturing and R&D capabilities, enabling breakthrough designs and performance previously beyond the limits of conventional manufacturing. CARLSBAD, Calif.
Construction Partners, Inc. to Participate in the Baird 2026 Global Industrial Conference
DOTHAN, Ala., Nov. 6, 2026 /PRNewswire/ -- Construction Partners, Inc. (NASDAQ: ROAD) (the "Company"), a vertically integrated civil infrastructure company specializing in the construction and maintenance of roadways in local markets throughout the Sunbelt, today announced that it will participate in the Baird 2026 Global Industrial Conference...
SAGA Metals Joins Canadian Chamber of Commerce and Critical Minerals Council
Vancouver, British Columbia--(Newsfile Corp. - November 6, 2026) - SAGA Metals Corp. (TSXV: SAGA) (OTCQX: SAGMF) (FSE: 20H) ("SAGA" or the "Company"), a North American exploration company focused on critical mineral discoveries, is pleased to announce that it has joined the Canadian Chamber of Commerce and its Critical Minerals Council. The membership positions SAGA within Canada's primary federal business advocacy network at a time of significant national focus on critical minerals, clean energy infrastructure, and North American supply-chain security...
Gogo Completes Amendment and Extension of ~$600 Million Term Loan B Deleveraging Transaction
Reaffirms Company's commitment to strengthening its financial position through deleveraging Term Loan B maturity extended to 2030 and debt reduced by $75 million through 2027, with immediate $25 million paydown BROOMFIELD, Colo., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Gogo Inc. (NASDAQ: GOGO) (“Gogo” or the “Company”), a leading global provider of broadband connectivity services for the business and military/government aviation markets, today announced it has completed an amendment and extension of its Term Loan B, supported by subsantially all holders...
ZenaTech's Drone as a Service Enters Solar Surveying Market with U.S. School Contract Wins, Targeting $600,000 in Revenue from First Solar Client
VANCOUVER, British Columbia, Nov. 06, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces that its Drone as a Service business has entered the solar surveying market with two contract awards totaling more than $110,000 for solar school campus and municipal projects. A third project valued at about $60,000 is expected to be awarded within 90 days, and management expects the client to generate roughly $150,000 in revenue per quarter, or about $600,000 over the next 12 months...
Quoin Pharmaceuticals' Latest NETHERTON NOW Video Details the Life of a Family Living with Netherton Syndrome
Kristi and Kodi Share Their Experience Living with the Rare Genetic Skin Disease, Alongside Insights from Pediatric Dermatologist Moise Levy, MD Kodi, who lives with Netherton Syndrome, in the latest NETHERTON NOW episode. ASHBURN, Va.
BioCardia Completes Clinical Consultation Process with Japan's PMDA for CardiAMP Cell Therapy System, Advancing Toward Submission of Marketing Approval Application
SUNNYVALE, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that it has completed the process with Japan's Pharmaceuticals and Medical Devices Agency (PMDA) concerning the application materials required to obtain regulatory approval in Japan for its CardiAMP Cell Therapy System ("CardiAMP") for the treatment of ischemic heart failure...
High Roller Technologies Engages Kindbridge Behavioral Health to Expand Support for Prediction Market Traders
Program combines access to specialized care for traders, customer service training and counseling for U.S. employees and their families LAS VEGAS, Nevada, Nov. 06, 2026 (GLOBE NEWSWIRE) -- High Roller Technologies, Inc. (“High Roller” or the “Company”) (NYSE: ROLR), an online gaming and prediction markets company, today announced that it has entered into a services agreement with Kindbridge Behavioral Health (“Kindbridge”) to provide specialized behavioral health support for eligible U.S. customers and employees. The engagement is expected to establish a confidential pathway to care for customers experiencing difficulties related to trading, supported by staff training and company-funded trader care...
CG Oncology Reports Third Quarter 2026 Financial Results and Provides Business Updates
DALLAS, Nov. 06, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today reported financial results for the third quarter ended September 30, 2026, and provided business updates.
Tredegar Reports Third Quarter 2026 Results
RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Corporation (NYSE:TG, also the “Company” or “Tredegar”) today reported third quarter financial results for the period ended September 30, 2026. CEO Commentary “We are well on the way on our journey to re-engineer Tredegar into a stronger operating company and create sustainable shareholder value,” said Dr. Arijit (Bapi) DasGupta, president and chief executive officer. “Thus far in 2026, we have made substantial progress through our One Tredegar initiativ...
Aura Announces Q3 2026 and 9M 2026 Financial and Operational Results
ROAD TOWN, British Virgin Islands, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (NASDAQ: AUGO) (B3: AURA33) (“Aura” or the “Company”) announces that it has filed its audited consolidated financial statements and earnings release (together, “Financial and Operational Results”) for the period ended June 30, 2026. The full version of the Financial and Operational Results can be viewed on the Company's website at www.auraminerals.com, on SEDAR+ at www.sedarplus.ca...
FactSet Declares Dividend
NORWALK, Conn., Nov. 06, 2026 (GLOBE NEWSWIRE) -- FactSet (NYSE: FDS | NASDAQ: FDS), a leading global intelligence and AI solutions provider to the financial markets, today announced that its Board of Directors approved a regular quarterly cash dividend of $1.16 per share.
MNTN, Inc. (MNTN) Investors Who Suffered Losses Encouraged to Contact Johnson Fistel Regarding Securities Investigation
SAN DIEGO--(BUSINESS WIRE)---- $MNTN #InvestorAlert--Johnson Fistel, PLLP is investigating potential securities claims on behalf of MNTN, Inc. (NYSE: MNTN) investors following the stock's approximately 50% decline on November 5, 2026. The investigation concerns whether MNTN adequately disclosed the effects of changes to its sales organization on customer acquisition and revenue growth.What if I purchased MNTN securities?If you purchased MNTN securities and suffered losses, contact Johnson Fistel to learn more about the...
Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference
PRINCETON, N.J., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, will present at the 2026 UBS Global Healthcare Conference on Monday, November 9, 2026, at 2:45 p.m. ET...
Once-Weekly TransCon® CNP (Navepegritide) to Receive 10 Years of Market Exclusivity Upon Approval in the European Union
– Final European Commission decision expected during Q4 2026 COPENHAGEN, Denmark, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending maintenance of orphan medicinal product designation for once-weekly TransCon CNP (navepegritide) as a treatment for achondroplasia in children. The designation would provide Ascendis benefits that include 10 years of orphan market exclusivity upon final adoption of the COMP opinion by the European Commission (EC)...
BitFuFu Announces October 2026 Bitcoin Production and Operational Updates
SINGAPORE, Nov. 06, 2026 (GLOBE NEWSWIRE) -- BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited Bitcoin production and operational metrics for October 2026.
Protara Therapeutics Announces Third Quarter 2026 Financial Results and Provides a Business Update
Expect to complete enrollment of the BCG-Unresponsive registrational cohort of the ADVANCED-2 trial of TARA-002 in NMIBC by year-end 2026
REV Receives Final Approval for CSE Listing, Commences Completions at Aden
Shares of REV to begin trading on the CSE on November 9, 2026 New REV Video: Why Helium Matters KELOWNA, British Columbia, Nov. 06, 2026 (GLOBE NEWSWIRE) -- REV Exploration Corp. (“REV” or the “Company”) (TSXV: REVX; CSE: REVX, effective November 9, 2026; OTC: REVFF; FSE: 7FF) is pleased to announce that it has received final approval from the Canadian Securities Exchange (the “CSE”) to list the Company's common shares (the “Common Shares”) on the CSE (the “Listing”). The Common Shares will commence trading on the CSE at market open on Monday, November 9, 2026, with no change in the trading symbol (“REVX”) or the CUSIP/ISIN...
Acrivon Expands into Immunology and Inflammation with Acquisition of Phase 2-Ready Differentiated, Oral JAK1 Inhibitor ACR-525, and PKCθ Inhibitor Preclinical Program from Aqilion AB
Asset acquisition establishes immunology and inflammation (I&I) as a strategic pillar alongside oncology, extending the company into autoimmune disease
EchoPark Automotive Teams Up with Owen Wilson for Its Largest Campaign
Campaign launches Nov. 8 during NFL broadcasts, bringing "Every Car, Happy Owner" to more shoppers CHARLOTTE, N.C., Nov. 6, 2026 /PRNewswire/ -- EchoPark Automotive is teaming up with Owen Wilson as its new spokesperson for the largest single-brand marketing investment in its history, launching Nov. 8 during Sunday NFL broadcasts in EchoPark markets...
Bending Spoons to announce Q3 2026 results
MILAN, Italy, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Bending Spoons S.p.A. (Nasdaq: BSP) today announced it will release financial results for Q3 2026 on November 20, 2026, before the U.S. market opens.
NowVertical Announces Separation Agreement With Former CEO
TORONTO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) (the “Company” or “NowVertical”), announces that it has entered into a separation agreement (the “Separation Agreement”) with Sandeep Mendiratta, the former Chief Executive Officer of the Company.
MIMEDX to Participate in Upcoming Investor Conferences
MARIETTA, Ga., Nov. 06, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DALLAS, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on November 2, 2026, the Compensation Committee of Taysha's Board of Directors granted two new employees, in the aggregate, restricted stock units (RSUs) representing 25,000 shares of the Company's common stock in connection with their employment. The RSUs were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4)...
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
RADNOR, Pa., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone, announced today that, on November 3, 2026, the Compensation Committee of Mineralys' Board of Directors granted an inducement stock option award covering 14,880 shares and an inducement restricted stock unit award covering 11,160 shares of Mineralys common stock to a new non-executive employee...
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today reported recent business progress and financial results for the third quarter 2026...
SABINE ROYALTY TRUST ANNOUNCES MONTHLY CASH DISTRIBUTION FOR NOVEMBER 2026
DALLAS, Nov. 6, 2026 /PRNewswire/ -- Argent Trust Company, as Trustee of the Sabine Royalty Trust (NYSE: SBR), today declared a cash distribution to the holders of its units of beneficial interest of $0.360390 per unit, payable on November 30, 2026, to unit holders of record on November 16, 2026. Sabine's cash distribution history, current and prior year financial reports and tax information booklets, a link to filings made with the Securities and Exchange Commission and more can be found on its website at http://www.sbr-sabine.com/...
Dauch Reports Third Quarter 2026 Financial Results
Delivers Strong Operating Cash Flow DETROIT, Nov. 6, 2026 /PRNewswire/ -- Dauch Corporation ("Dauch") (NYSE: DCH; LSE: DCH) today reported its financial results for the third quarter 2026. Third Quarter 2026 Results Sales of $2.91 billion Net loss attributable to Dauch of $(45.3) million, or (1.6)% of sales Adjusted EBITDA of $358.5 million, or 12.3% of sales Diluted loss per share of $(0.19); Adjusted earnings per share of $0.22 Net cash provided by operating activities of $150.1 million; Adjusted free cash flow of $126.7 million "We generated strong cash flow in the quarter while supporting new program launches," said Chairman and Chief Executive Officer David C...
enGene to Participate in Upcoming Investor Conferences
BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Therapeutics Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company today announced that management will participate in the following investor conferences: UBS Global Biopharma Conference 2026 Date: Monday, November 16, 2026 Time: 3:20 p.m. GMT / 10:20 a.m. ET Format: Fireside Chat Jefferies Global Healthcare Conference in London Date: Thursday, November 19, 2026 Time: 10:30 a.m. GMT / 5:30 a.m. ET Format:...
Teledyne to Participate in the Baird Global Industrial Conference
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Teledyne Technologies Incorporated (NYSE:TDY) today announced that George Bobb, President and Chief Executive Officer, Jason VanWees, Vice Chairman, and Mary Grace DeForest Berg, Vice President, Investor Relations and Mergers & Acquisitions, will hold investor meetings at the Baird 2026 Global Industrial Conference on Wednesday, November 11. Teledyne's latest investor presentation is publicly available on the Company's website at www.teledyne.com/inve...
Enhanced Group to Report Third Quarter 2026 Financial Results
NEW YORK--(BUSINESS WIRE)--Enhanced Group Inc. (NYSE: ENHA), a sports, entertainment and performance products company, today announced it will report financial results for the third quarter 2026 on November 12, 2026 after the U.S. stock market closes. Management will host a conference call and webcast the same day at 4:30 PM ET to discuss the results. The live webcast, along with the accompanying investor materials, will be accessible at investors.enhanced.com. About Enhanced Group, Inc. Enhanc...
Marcus & Millichap, Inc. Reports Results for Third Quarter 2026
CALABASAS, Calif.--(BUSINESS WIRE)--Marcus & Millichap, Inc. (the “Company”, “Marcus & Millichap”, or “MMI”) (NYSE: MMI), a leading national real estate services firm specializing in commercial real estate investment sales, financing services, research and advisory services, reported its third quarter financial results today. Third Quarter 2026 Highlights Compared to Third Quarter 2025 Total revenue increased by 7.5% to $208.4 million, compared to $193.9 million Brokerage commissions in...
Fifth Third Private Bank Named Best Private Bank for Customer Service in the U.S. at 2026 Global Private Banking Awards
CINCINNATI--(BUSINESS WIRE)--Fifth Third Private Bank, a division of Fifth Third Bancorp (NYSE: FITB), has been named the Best Private Bank for Customer Service, United States. The award was presented in London as part of the 2026 Global Private Banking Awards from The Banker and Professional Wealth Management, publications of the Financial Times group. The recognition is Fifth Third Private Bank's sixth industry award of 2026 and its third this year specifically honoring client service or exper...
AMETEK Declares Quarterly Dividend
BERWYN, Pa., Nov. 6, 2026 /PRNewswire/ -- The Board of Directors of AMETEK, Inc. (NYSE: AME) declared a regular quarterly dividend of $0.34 per share for the fourth quarter ending December 31, 2026.
FIRST BANK EXPANDS CHARLOTTE PRESENCE WITH NEW SOUTHPARK BRANCH AND OFFICE
Strategic investment strengthens First Bank's presence and supports growth in the Charlotte market CHARLOTTE, N.C., Nov. 6, 2026 /PRNewswire/ -- First Bank, a subsidiary of First Bancorp (NASDAQ: FBNC), announced the opening of its new SouthPark branch and office, marking an important milestone for the bank and a significant investment in its continued growth in Charlotte...